BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank57
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P57
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -18.52% |
| 2024 | -3.38% |
| 2023 | -100.90% |
| 2022 | -60.55% |
| 2021 | -535.98% |
| 2020 | 69.63% |
| 2019 | -3.34% |
| 2018 | -159.16% |
| 2017 | -21.12% |
| 2016 | -33.01% |